News
Our researchers are developing fast and portable virus sequencing techniques to track viruses in areas with limited medical ...
4h
News-Medical.Net on MSNNew antiviral compounds show broad protection against COVID-19 variantsAVI-4303, which is a C5 benzotriazole analog, exhibited ten-fold higher potency than AVI-3318. Comparatively, N1 propargyl ...
Multisystem inflammatory syndrome in children (MIS-C) linked to COVID-19 is associated with reactivation of Epstein-Barr virus (EBV), leading to an altered immune response, according to a study ...
Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome ... designed the new compound to target a structure in the virus called its papain ...
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine as a post-approval commitment, a source familiar with the ...
Now it’s a website fully dedicated to President Donald Trump’s theory the COVID-19 pandemic originated from a research lab in Wuhan, China. It’s been more than five years since the onset of ...
It’s been five years since the World Health Organization declared COVID-19 a pandemic, turning our lives upside down. It’s not exactly an anniversary anyone wants to celebrate. But there is ...
WASHINGTON — Novavax’s closely watched COVID-19 vaccine is on track for full approval after additional discussions with the Food and Drug Administration, the company said Wednesday.
Federal drug regulators have missed the deadline for making a key decision regarding a Covid-19 vaccine from Novavax, days after the Food and Drug Administration’s vaccine chief was pushed out.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results